Koppel Adam 4
4 · Foghorn Therapeutics Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Koppel Adam
Director
Transactions
- Award
Stock Options (Right to buy)
2024-06-26$5.52/sh+16,000$88,320→ 16,000 totalExercise: $5.52From: 2025-06-26Exp: 2034-06-25→ Common Stock (16,000 underlying)